427 related articles for article (PubMed ID: 3825169)
1. [Hemorheologic therapy applications in coronary heart disease].
Leschke M; Motz W; Strauer BE
Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
[TBL] [Abstract][Full Text] [Related]
2. Blood rheology and physiology of microcirculation.
Schmid-Schönbein H
Ric Clin Lab; 1981; 11 Suppl 1():13-33. PubMed ID: 7188106
[TBL] [Abstract][Full Text] [Related]
3. [Rheology and coronary heart disease].
Leschke M
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S270-3. PubMed ID: 19085805
[TBL] [Abstract][Full Text] [Related]
4. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
Sternitzky R; Seige K
Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
[TBL] [Abstract][Full Text] [Related]
5. [Hemorrheological changes in ischemic heart disease].
Forconi S; Guerrini M; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():195-208. PubMed ID: 6672996
[TBL] [Abstract][Full Text] [Related]
6. Changes in blood filterability in cerebrovascular accidents.
Boisseau MR; Freyburger G; Lorient-Roudaut MF
Wien Med Wochenschr; 1986; 136 Spec No():44-6. PubMed ID: 3825170
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of blood viscosity and erythrocyte filterability in chronic ischemic heart disease].
Strano A; Avellone G; Novo S; Davì G; Di Garbo V
Ric Clin Lab; 1985; 15 Suppl 1():179-84. PubMed ID: 4035213
[TBL] [Abstract][Full Text] [Related]
8. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte aggregation in clinical medicine.
Ehrly AM
Klin Wochenschr; 1986 Oct; 64(20):1081-4. PubMed ID: 3784459
[TBL] [Abstract][Full Text] [Related]
10. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
[TBL] [Abstract][Full Text] [Related]
11. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes.
Pfafferott C; Moessmer G; Ehrly AM; Bauersachs RM
Clin Hemorheol Microcirc; 1999; 21(1):35-43. PubMed ID: 10517486
[TBL] [Abstract][Full Text] [Related]
12. [Effect of therapeutic plasmapheresis on rheological properties of blood in patients with ischemic heart disease].
Zadionchenko VS; Bezprozvannyĭ AB; Dzhanashiia PKh; Romashkin AV; Kuznetsova EIu; Borzova LV; Dobashina AN
Sov Med; 1991; (10):3-6. PubMed ID: 1801230
[TBL] [Abstract][Full Text] [Related]
13. [Hemodilution].
Landgraf H
Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
[TBL] [Abstract][Full Text] [Related]
14. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
[TBL] [Abstract][Full Text] [Related]
15. [Hemorheologic findings in patients with ischemic heart disease].
Kunsch R; Bull K; Moufti M; Richter T; Schäbitz J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(5):803-5. PubMed ID: 2481631
[TBL] [Abstract][Full Text] [Related]
16. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
Wiek J; Krause M; Wiederholt M; Hansen LL
Fortschr Ophthalmol; 1990; 87(6):671-4. PubMed ID: 2086417
[TBL] [Abstract][Full Text] [Related]
17. [Flow characteristics of blood and its therapeutic modification].
Reinhart WH
Schweiz Med Wochenschr; 1987 May; 117(18):693-7. PubMed ID: 3589626
[TBL] [Abstract][Full Text] [Related]
18. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
[TBL] [Abstract][Full Text] [Related]
19. [Isovolemic hemodilution in patients with coronary heart disease].
Kiesewetter H; Erlenwein S; Jung F; Wenzel E; Vogel W; Dyckmans J; Bach R; Hahmann H; Schieffer H; Bette L
Klin Wochenschr; 1988; 66 Suppl 15():8-14. PubMed ID: 3184787
[TBL] [Abstract][Full Text] [Related]
20. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
